Isabel Clémançon de Bellefois

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
TRO40303 is cytoprotective compound that was shown to reduce infarct size in preclinical models of myocardial infarction. It targets mitochondria, delays mitochondrial permeability transition pore (mPTP) opening and reduces oxidative stress in cardiomyocytes submitted to ischemia/reperfusion in vitro. Because the involvement of the mitochondria and the mPTP(More)
  • 1